Fredric I. Orkin

HemoCleanse, Inc. develops sorbent-based technologies to remove toxins from blood. It offers HemoCleanse-DT, a sorbent-based centrifuge-like device for liver dialysis and drug overdose detoxification applications; and HemoCleanse-PF, a sorbent-based centrifuge-like device for removing protein-bound toxins from plasma in applications, such as treatment of sepsis and autoimmuned diseases. The firm also provides AmSorb Ammonium sorbent for use in HemoCleanse; as an oral sorbent for urea control in the treatment of patients with renal insufficiency or end stage renal disease; and for ammonium removal in treatment of patients with chronic liver diseases. The company was founded by Stephen R. Ash and Robert B. Truitt in 1989 and is headquartered in Lafayette, IN.

Advanced Analytical Technologies, Inc. manufactured rapid detection and enumeration systems for biomass organisms. The company was founded by Steven J. Lasky and Daniel Buttry in 1997 and was headquartered in Ankeny, IA.

Renal Solutions, Inc. develops, manufactures and distributes medical devices for dialysis. It commercializes the Allient Sorbent Hemodialysis Systems, a technology/service solution for the chronic and acute dialysis market. The company was founded by Peter M. DeComo on August 1, 2000 and is headquartered in Warrendale, PA.